Recently, the State Drug Administration and the General Administration of Customs jointly issued a notice to add the port port of Qinzhou in Guangxi Zhuang Autonomous Region as an import border port for medicinal herbs with the approval of the State Council. This is the country's first seaport herbal medicine import border port. It is also an important achievement for Guangxi to serve the common destiny of China and ASEAN and jointly build a new land and sea corridor in the west. It will enhance the resilience of the supply chain of the biomedical industry chain throughout the region and unblock trade channels for Chinese herbal medicines between China and ASEAN countries. According to the announcement, from the date of publication, Chinese herbal medicines can be imported through the port of Qinzhou, and imported medicinal herbs must comply with the “Administrative Measures on Imported Herbal Medicines” and other relevant regulations. The Qinzhou Market Supervision Administration is the corresponding port drug supervision and administration department for the Qinzhou port. It undertakes the registration and filing of imported medicinal materials, organization of port inspection, and supervision and administration of imported medicinal materials at the port of Qinzhou. The Guangxi Zhuang Autonomous Region Drug Inspection Research Institute is the Qinzhou port drug inspection agency and officially undertakes the port's herbal medicine inspection work.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.